How Quantum Simulation Is Changing Drug Discovery
transcript
show notes
Most quantum hype focuses on factoring or optimization, but the near-term commercial reality is in simulation. In this episode, Lucas and Luna examine how companies like IonQ and Rigetti are using noisy intermediate-scale quantum devices to model molecular interactions for pharmaceutical development. We look at the specific challenge of simulating protein folding and why classical supercomputers hit a wall with complex chemical bonds. The conversation covers the shift from theoretical physics to practical enterprise software partnerships, analyzing the roadmaps from hardware providers and what 'quantum advantage' actually looks like for drug discovery pipelines today. It is not about breaking encryption; it is about understanding nature at the atomic level.
#QuantumComputing #DrugDiscovery #PharmaceuticalIndustry #MolecularSimulation #IonQ #Rigetti #BiotechInnovation #EnterpriseQuantum #HardwareSoftware #BusinessPodcast #FexingoBusiness #TechTrends2026 #QuantumAdvantage #ProteinFolding #ChemicalEngineering #VentureCapital #DeepTech #ScienceAndBusiness
